Skip to search formSkip to main contentSkip to account menu

aditoprim

Known as: 2,4-diamino-5-(4-(dimethylamino)-3,5-dimethoxybenzyl)pyrimidine 
A long-acting, selective, reversible inhibitor of dihydrofolate reductase with application as a broad-spectrum antibacterial agent in animals.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Aditoprim, a new bacteriostatic agent that belongs to diaminopyrimidines, has a broad antimicrobial spectrum, good antibacterial… 
2015
2015
Aditoprim (ADP), a new developed dihydrofolate reductase (DHFR) inhibitor, has great potential in clinical veterinary medicine… 
1992
1992
Plasma disposition of aditoprim, a new dihydrofolate reductase inhibitor, was studied in healthy cows and cows with endotoxin… 
1991
1991
The pharmacokinetics of aditoprim (2,4-diam-ino-5-[4-[dimethylamino]-3,5-dimethoxybenzyl] pyrimidine), a dihydrofolate reductase… 
1990
1990
Aditoprim, a broad spectrum antimicrobial agent acting as a reversible dihydrofolate reductase inhibitor, was intravenously… 
1990
1990
The in vitro antimicrobial activities of aditoprim (AP), a new dihydrofolate reductase (DHFR) inhibitor, trimethoprim (TMP… 
1990
1990
The in vitro activity of flumequine in comparison with several other drugs was tested against 17 P. multocida, 16 P. haemolytica… 
1988
1988
Aditoprim (AP) is a new dihydrofolate reductase inhibitor, which is structurally related to trimethoprim (TMP). The… 
1988
1988
Summary The affinity of aditoprim (ADM), a new selective inhibitor of bacterial dihydrofolate reductases (DHFR), was two- to… 
1987
1987
Summary The pharmacokinetics of aditoprim, a new dihydrofolate reductase (DHFR) inhibitor, and trimethoprim (TMP) were studied…